{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:27:39Z","timestamp":1786368459462,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Anaplastic lymphoma kinase (ALK) rearrangement status examination has been widely used in clinic for non-small cell lung cancer (NSCLC) patients in order to find patients that can be treated with targeted ALK inhibitors. This study intended to non-invasively predict the ALK rearrangement status in lung adenocarcinomas by developing a machine learning model that combines PET\/CT radiomic features and clinical characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Five hundred twenty-six patients of lung adenocarcinoma with PET\/CT scan examination were enrolled, including 109 positive and 417 negative patients for ALK rearrangements from February 2016 to March 2019. The Artificial Intelligence Kit software was used to extract radiomic features of PET\/CT images. The maximum relevance minimum redundancy (mRMR) and least absolute shrinkage and selection operator (LASSO) logistic regression were further employed to select the most distinguishable radiomic features to construct predictive models. The mRMR is a feature selection method, which selects the features with high correlation to the pathological results (maximum correlation), meanwhile retain the features with minimum correlation between them (minimum redundancy). LASSO is a statistical formula whose main purpose is the feature selection and regularization of data model. LASSO method regularizes model parameters by shrinking the regression coefficients, reducing some of them to zero. The feature selection phase occurs after the shrinkage, where every non-zero value is selected to be used in the model. Receiver operating characteristic (ROC) analysis was used to evaluate the performance of the models, and the performance of different models was compared by the DeLong test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 22 radiomic features were extracted from PET\/CT images for constructing the PET\/CT radiomic model, and majority of these features used were based on CT features (20 out of 22), only 2 PET features were included (PET percentile 10 and PET difference entropy). Moreover, three clinical features associated with ALK mutation (age, burr and pleural effusion) were also employed to construct a combined model of PET\/CT and clinical model. We found that this combined model PET\/CT-clinical model has a significant advantage to predict the ALK mutation status in the training group (AUC = 0.87) and the testing group (AUC = 0.88) compared with the clinical model alone in the training group (AUC = 0.76) and the testing group (AUC = 0.74) respectively. However, there is no significant difference between the combined model and PET\/CT radiomic model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study demonstrated that PET\/CT radiomics-based machine learning model has potential to be used as a non-invasive diagnostic method to help diagnose ALK mutation status for lung adenocarcinoma patients in the clinic.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.603882","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T14:45:05Z","timestamp":1614696305000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":63,"title":["A Machine Learning Model Based on PET\/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Cheng","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maomei","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review","volume":"322","author":"Arbour","year":"2019","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2020.01.008","article-title":"Epidermal Growth Factor Receptor Mutations","volume":"30","author":"McLoughlin","year":"2020","journal-title":"Thorac Surg Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2019.12.001","article-title":"Anaplastic Lymphoma Kinase Mutation-Positive Non-Small Cell Lung Cancer","volume":"30","author":"Serritella","year":"2020","journal-title":"Thorac Surg Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2020.01.007","article-title":"ROS1-rearranged Non-small Cell Lung Cancer","volume":"30","author":"Giustini","year":"2020","journal-title":"Thorac Surg Clin"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.10.22","article-title":"Targeting BRAF mutations in non-small cell lung cancer","volume":"8","author":"O\u2019Leary","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12613","article-title":"ALK-rearrangement in non-small-cell lung cancer (NSCLC)","volume":"9","author":"Du","year":"2018","journal-title":"Thorac Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182904e22","article-title":"Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant","volume":"8","author":"To","year":"2013","journal-title":"J Thorac Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31821cfc73","article-title":"Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression","volume":"6","author":"Kim","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0139264","DOI":"10.1371\/journal.pone.0139264","article-title":"Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma","volume":"10","author":"Zito Marino","year":"2015","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.8293","article-title":"Intratumoral Heterogeneity of ALK-Rearranged and ALK\/EGFR Coaltered Lung Adenocarcinoma","volume":"33","author":"Cai","year":"2015","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.07.024","article-title":"Additional local consolidative therapy has survival benefit over EGFR tyrosine kinase inhibitors alone in bone oligometastatic lung adenocarcinoma patients","volume":"135","author":"Hu","year":"2019","journal-title":"Lung Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.breast.2019.10.018","article-title":"Overview of radiomics in breast cancer diagnosis and prognostication","volume":"49","author":"Tagliafico","year":"2020","journal-title":"Breast"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9501","DOI":"10.1038\/s41598-019-45053-x","article-title":"Radiomics based likelihood functions for cancer diagnosis","volume":"9","author":"Shakir","year":"2019","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cllc.2016.02.001","article-title":"Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas","volume":"17","author":"Liu","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-018-1660-7","article-title":"Radiomics and radiogenomics of prostate cancer","volume":"44","author":"Smith","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.lungcan.2017.10.015","article-title":"Radiomics and radiogenomics in lung cancer: A review for the clinician","volume":"115","author":"Thawani","year":"2018","journal-title":"Lung Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00057","article-title":"CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40644-018-0184-2","article-title":"CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses","volume":"18","author":"Mei","year":"2018","journal-title":"Cancer Imaging"},{"key":"B21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40644-019-0221-9","article-title":"CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma","volume":"19","author":"Shen","year":"2019","journal-title":"Cancer Imaging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/1759-7714.13352","article-title":"Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas","volume":"11","author":"Yoon","year":"2020","journal-title":"Thorac Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/srep41674","article-title":"Predictive radiogenomics modeling of EGFR mutation status in lung cancer","volume":"7","author":"Gevaert","year":"2017","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00369","article-title":"Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients","volume":"10","author":"Song","year":"2020","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-019-01112-x","article-title":"Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (\u22643cm): PET\/CT findings and correlations with lymph node metastasis","volume":"125","author":"Chang","year":"2020","journal-title":"Radiol Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.acra.2020.01.030","article-title":"SUVmax of (18)FDG PET\/CT Predicts Histological Grade of Lung Adenocarcinoma","volume":"28","author":"Sun","year":"2021","journal-title":"Acad Radiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04652-6","article-title":"Correlation between combining (18)F-FDG PET\/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer","volume":"47","author":"Ruan","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5802-7","article-title":"MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer","volume":"29","author":"Liu","year":"2019","journal-title":"Eur Radiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2861","article-title":"Radiomics on Gadoxetic Acid\u2013Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma","volume":"13","author":"Kim","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its Associated Cutoff Point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11864-020-00741-z","article-title":"TRK Inhibitors in Non-Small Cell Lung Cancer","volume":"21","author":"Harada","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027187","article-title":"First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer","author":"Shaw","year":"2020","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0229179","DOI":"10.1371\/journal.pone.0229179","article-title":"ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis","volume":"15","author":"Elliott","year":"2020","journal-title":"PLoS One"},{"key":"B34","article-title":"Targeted Therapy for Mutation-Driven Metastatic Non-Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors","volume":"33","author":"Mileham","year":"2019","journal-title":"Oncol (Williston Park)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70259-0","article-title":"ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy","volume":"2","author":"Rosell","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.11.117","article-title":"Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project","volume":"13","author":"Letovanec","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e70839","DOI":"10.1371\/journal.pone.0070839","article-title":"Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/modpathol.2017.181","article-title":"Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer","volume":"31","author":"Rosenbaum","year":"2018","journal-title":"Mod Pathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140789","article-title":"ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization","volume":"272","author":"Yamamoto","year":"2014","journal-title":"Radiology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019182023","article-title":"Validation of A Method to Compensate Multicenter Effects Affecting CT Radiomics","volume":"291","author":"Orlhac","year":"2019","journal-title":"Radiology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-020-01487-8","article-title":"Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms","volume":"22","author":"Shiri","year":"2020","journal-title":"Mol Imaging Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00272","article-title":"Radiomic machine-learning classifiers for prognostic biomarkers of head and neck cancer","author":"Parmar","year":"2015","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.08.232","article-title":"Noninvasive O6 methylguanine-DNA methyltransferase status prediction in glioblastoma multiforme cancer using magnetic resonance imaging radiomics features: univariate and multivariate radiogenomics analysis","volume":"132","author":"Hajianfar","year":"2019","journal-title":"World Neurosurg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13206","DOI":"10.1038\/s41598-017-13448-3","article-title":"A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling","author":"Leger","year":"2017","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.diii.2020.01.008","article-title":"Radiomics for classification of bone mineral loss: A machine learning study","volume":"101","author":"Rastegar","year":"2020","journal-title":"Diagn Interv Imaging"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.603882\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T14:45:13Z","timestamp":1614696313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.603882\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":45,"alternative-id":["10.3389\/fonc.2021.603882"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.603882","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"article-number":"603882"}}